High-Dose Lovastatin for Acute Ischemic Stroke: Results of the Phase I Dose Escalation Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)

BACKGROUND: Hydroxymethylglutaryl coenzyme A reductase inhibitors (‘statins’) reduce the neuronal injury in dose-dependent fashion in rodent stroke models. We sought to determine whether lovastatin at doses above those currently approved can be administered safely within 24 h after an acute ischemic...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Elkind, Mitchell S.V., Sacco, Ralph L., MacArthur, Robert B., Peerschke, Ellinor, Neils, Greg, Andrews, Howard, Stillman, Joshua, Corporan, Tania, Leifer, Dana, Liu, Rui, Cheung, Ken
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2009
Teme:
Original Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2814015/
https://ncbi.nlm.nih.gov/pubmed/19609078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000228709
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items